These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21912232)

  • 1. The new therapeutic concept of using a rho kinase inhibitor for the treatment of corneal endothelial dysfunction.
    Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Hamuro J; Kinoshita S
    Cornea; 2011 Oct; 30 Suppl 1():S54-9. PubMed ID: 21912232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models.
    Koizumi N; Okumura N; Kinoshita S
    Exp Eye Res; 2012 Feb; 95(1):60-7. PubMed ID: 22067130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue.
    Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Tsuchiya H; Hamuro J; Kinoshita S
    Am J Pathol; 2012 Jul; 181(1):268-77. PubMed ID: 22704232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops.
    Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Hirata K; Torii R; Hamuro J; Kinoshita S
    Br J Ophthalmol; 2011 Jul; 95(7):1006-9. PubMed ID: 21398412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing.
    Okumura N; Koizumi N; Kay EP; Ueno M; Sakamoto Y; Nakamura S; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2493-502. PubMed ID: 23462749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor.
    Okumura N; Ueno M; Koizumi N; Sakamoto Y; Hirata K; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3680-7. PubMed ID: 19387080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Rho Kinase Inhibitors in Corneal Endothelial Dysfunction.
    Okumura N; Kinoshita S; Koizumi N
    Curr Pharm Des; 2017; 23(4):660-666. PubMed ID: 27917718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cyclin D and p27 in cell proliferation mediated by ROCK inhibitors Y-27632 and Y-39983 during corneal endothelium wound healing.
    Okumura N; Nakano S; Kay EP; Numata R; Ota A; Sowa Y; Sakai T; Ueno M; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):318-29. PubMed ID: 24106120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye drops.
    Koizumi N; Okumura N; Ueno M; Kinoshita S
    Cornea; 2014 Nov; 33 Suppl 11():S25-31. PubMed ID: 25289721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Rho Kinase Inhibitor Y-27632 on Corneal Endothelial Wound Healing.
    Okumura N; Inoue R; Okazaki Y; Nakano S; Nakagawa H; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):6067-74. PubMed ID: 26393474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stimulatory effect of ROCK inhibitor on bovine corneal endothelial cells.
    Li S; Wang C; Dai Y; Yang Y; Pan H; Zhong J; Chen J
    Tissue Cell; 2013 Dec; 45(6):387-96. PubMed ID: 23909974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing.
    Okumura N; Okazaki Y; Inoue R; Kakutani K; Nakano S; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1284-92. PubMed ID: 26998714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal Endothelial Cell Migration and Proliferation Enhanced by Rho Kinase (ROCK) Inhibitors in In Vitro and In Vivo Models.
    Meekins LC; Rosado-Adames N; Maddala R; Zhao JJ; Rao PV; Afshari NA
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6731-6738. PubMed ID: 27951595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y-27632 Promotes the Repair Effect of Umbilical Cord Blood-Derived Endothelial Progenitor Cells on Corneal Endothelial Wound Healing.
    Zhang W; Shao C; Yu F; Chen J; Fu Y; Fan X
    Cornea; 2021 Feb; 40(2):203-214. PubMed ID: 33086282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction.
    Okumura N; Sakamoto Y; Fujii K; Kitano J; Nakano S; Tsujimoto Y; Nakamura S; Ueno M; Hagiya M; Hamuro J; Matsuyama A; Suzuki S; Shiina T; Kinoshita S; Koizumi N
    Sci Rep; 2016 May; 6():26113. PubMed ID: 27189516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and Feasibility Assessment of a New Vehicle for Cell-Based Therapy for Treating Corneal Endothelial Dysfunction.
    Okumura N; Kakutani K; Inoue R; Matsumoto D; Shimada T; Nakahara M; Kiyanagi Y; Itoh T; Koizumi N
    PLoS One; 2016; 11(6):e0158427. PubMed ID: 27355373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells.
    Lee HT; Kay EP
    Mol Vis; 2003 Dec; 9():624-34. PubMed ID: 14685150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROCK inhibitor enhances adhesion and wound healing of human corneal endothelial cells.
    Pipparelli A; Arsenijevic Y; Thuret G; Gain P; Nicolas M; Majo F
    PLoS One; 2013; 8(4):e62095. PubMed ID: 23626771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy.
    Kinoshita S; Koizumi N; Ueno M; Okumura N; Imai K; Tanaka H; Yamamoto Y; Nakamura T; Inatomi T; Bush J; Toda M; Hagiya M; Yokota I; Teramukai S; Sotozono C; Hamuro J
    N Engl J Med; 2018 Mar; 378(11):995-1003. PubMed ID: 29539291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF-2-induced wound healing in corneal endothelial cells requires Cdc42 activation and Rho inactivation through the phosphatidylinositol 3-kinase pathway.
    Lee JG; Kay EP
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1376-86. PubMed ID: 16565371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.